MarketPulse

stock price decline

513 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Faces Securities Class Action Over VYKAT XR Safety Disclosures

Hagens Berman files securities class action against $SLNO alleging concealed safety risks and inflated metrics for hyperphagia drug VYKAT XR. Stock crashed 27% following August activist report and November earnings miss.
SLNOinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

OneMain Under Fire: State AGs Sue Over Deceptive Lending Practices

New York and 12 state attorneys general sued OneMain Holdings for allegedly misleading borrowers with hidden loan costs. Stock fell 5.38%.
OMFclass action lawsuitstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Veritone Stock Crashes on $2.48M Revenue Restatement; Law Firm Launches Investor Investigation

Bragar Eagel & Squire investigates Veritone after $2.48M revenue restatement causes 8.33% stock decline to $2.09.
VERIclass action lawsuitsecurities investigation
BenzingaBenzinga··Glancy Prongay Wolke & Rotter Llp

PRCT Stock Plunges 15% After Weak Earnings, Securities Fraud Probe Widens

PROCEPT BioRobotics stock plunges 15% following disappointing earnings and cut guidance; securities fraud investigation underway seeking affected shareholders.
PRCTstock price declineshareholder litigation
BenzingaBenzinga··Law Offices Of Frank R. Cruz

PROCEPT BioRobotics Faces Securities Fraud Probe After Brutal Revenue Guidance Cut

PROCEPT BioRobotics faces securities fraud probe after slashing 2026 revenue guidance by up to $40M, citing eliminated bulk discounts. Stock fell 15.12%.
PRCTinvestor lossesstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

GoHealth Faces Securities Fraud Investigation Over Alleged Broker Kickbacks

Legal probe launched into $GOCO over alleged illegal kickbacks to brokers (2016-2021). Stock plunged 10.4% following DOJ False Claims Act complaint.
PODDGOCOAIROsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Law Offices Of Howard G. Smith

Medical Properties Trust Faces Securities Fraud Investigation After Major Tenant Default

Medical Properties Trust ($MPT) stock plunged 8% after declaring defaults on properties leased to Healthcare Systems of America, triggering a securities fraud investigation.
MPTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Aquestive Stock Tanks 37% on FDA Deficiency Letter; Class Action Lawsuit Filed

Pomerantz Law Firm filed securities fraud lawsuit against $AQST after FDA rejected Anaphylm NDA, triggering 37% stock drop. Investor deadline May 4.
EOSEAQSTNKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Nektar Therapeutics Faces Securities Fraud Class Action Over Failed Clinical Trial

Pomerantz LLP filed class action against $NKTR over REZOLVE-AA trial failure. Stock dropped 7.77% after December disclosure of ineligible patient enrollment issues.
NKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Corcept Therapeutics Hit With Class Action Suit After FDA Rejection Triggers 50% Stock Plunge

Pomerantz Law Firm files class action lawsuit against $CORT after FDA rejection of relacorilant causes 50.4% stock decline. Investors urged to act by April 21, 2026 deadline.
CORTEOSENKTRsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Boston Scientific Faces Class Action Over Earnings Miss; Stock Tumbles 17.6%

Boston Scientific faces class action lawsuit after 17.6% stock drop from weaker-than-expected electrophysiology sales; investors have until May 4, 2026 to join.
CWHBSXEOSEsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Driven Brands Stock Plunges 40% as Major Class Action Alleges Accounting Fraud

Portnoy Law Firm launches class action against Driven Brands ($DRVN) over accounting errors spanning 2023-2025, following 40% stock collapse.
DRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

PFSI Stock Plunges 33% Amid Servicing Income Collapse, Class Action Probe Launched

PennyMac Financial Services stock crashed 33.3% after Q4 2025 earnings revealed servicing pretax income collapsed 76% to $37.3M from $157.4M, prompting securities investigation.
PFSIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Chinese Tea Supplier Oriental Rise Faces Nasdaq Delisting After Stock Price Collapse

Oriental Rise ($ORIS) received delisting notice after falling below $1 minimum for 30 consecutive days, ineligible for standard compliance period due to December reverse split.
ORISstock price declinereverse stock split
BenzingaBenzinga··The Law Offices Of Frank R. Cruz

PicPay Holdings Faces Securities Fraud Probe After Credit Loss Disclosure Sparks 22.5% Plunge

Law firm investigates $PICS for potential securities violations after March 2026 disclosure of R$590M credit risk reclassification triggered steep stock decline.
PICSinvestor lossesfinancial disclosure
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

NUAI Stock Plummets 41% as Securities Lawsuit Alleges CEO Fraud Over Data Center Project

New Era Energy & Digital faces securities class action lawsuit alleging CEO and former CFO certified false statements about Texas data center project and undisclosed fraud scheme.
NUAINUAIWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Boston Scientific Hit With Securities Fraud Lawsuit Over Missed EP Guidance

Boston Scientific faces securities fraud lawsuit over undisclosed EP segment weakness, triggering 17.6% stock decline and May 4 lead plaintiff deadline.
BSXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

ATRA Stock Crashes 97% Total as FDA Rejects Cancer Drug Twice; Class Action Lawsuit Looms

Atara Biotherapeutics stock collapsed 97% across two FDA rejections for tabelecleucel. Class action deadline: May 22, 2026.
ATRAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Immutep Stock Collapses 82.6% After Failed Cancer Trial, Triggering Class Action

Immutep's $IMMP shares plummeted after discontinuing Phase III trial for cancer drug. Rosen Law Firm investigates potential securities fraud claims.
IMMPinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··The Rosen Law Firm

PennyMac Stock Crashes 33% as Servicing Income Collapses; Securities Probe Launched

PennyMac Financial Services ($PFSI) plummeted 33.3% after servicing segment income crashed 76% quarter-over-quarter, prompting securities investigation.
PFSIsecurities fraudclass action lawsuit